Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Share News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.50
Ask: 11.50
Change: 0.00 (0.00%)
Spread: 1.00 (9.524%)
Open: 11.00
High: 11.00
Low: 11.00
Prev. Close: 11.00
ABDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Abingdon Health rolls out Salistick in Tesco

Tue, 15th Aug 2023 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Abingdon Health PLC, up 27% at 11.1 pence, 12-month range 3.6p-18.5p. The lateral flow contract development and manufacturing company announces that UK grocery Tesco PLC will roll out saliva-based pregnancy test, Salistick. The product will be available in 298 stores and online from late August. Abingdon is the exclusive distributor of Salistick in the UK and Ireland on behalf of Salignostics Ltd, an Israeli developer of innovative saliva-based diagnostics tests. The Tesco launch follows the rollout across 400 Superdrug stores and online back in June.

----------

PHSC PLC, up 30% at 24p, 12-month range 11.55p-25.4p. The Kent-based health, safety, hygiene and environmental consultancy services provider begins another share buyback programme for the lower of 1.2 million shares or GBP200,000. Notes its closing price on Monday of 18.5p represents a "significant discount" to the last disclosed net asset value per share of around 30.7p as at March 31.

----------

AIM - LOSERS

----------

Velocity Composites PLC, down 2.5% at 41.44p, 12-month range 13.65p-68.55p. The supplier of composite material kits says it raises a further GBP190,000 via a conditional subscription for 475,000 shares at 40p each from a strategic investor. On Monday, the firm had said GBP1.4 million was raised via a placing, subscription and retail offer with 3.5 million shares issued. In addition, it raised GBP5 million through the issue of 12.5 million enterprise investment scheme/venture capital trust placing shares at 40p. Will use the funds for capital expenditure, people and working capital for expansion.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Feb 2021 12:12

Omega Diagnostics And Abingdon Note Encouraging Covid-19 Test Data

Omega Diagnostics And Abingdon Note Encouraging Covid-19 Test Data

Read more
16 Feb 2021 11:38

Abingdon Health, Omega Diagnostics Note "Highly Accurate" Covid Test

Abingdon Health, Omega Diagnostics Note "Highly Accurate" Covid Test

Read more
9 Feb 2021 11:18

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

Read more
8 Feb 2021 11:20

Abingdon Health Shares Slip On Media Speculation Around Covid Tests

Abingdon Health Shares Slip On Media Speculation Around Covid Tests

Read more
27 Jan 2021 19:17

IN BRIEF: Abingdon Health Says No More UK Government Orders Planned

IN BRIEF: Abingdon Health Says No More UK Government Orders Planned

Read more
29 Dec 2020 10:28

Abingdon Health Continues Work With Regulator For Covid Test Approval

Abingdon Health Continues Work With Regulator For Covid Test Approval

Read more
15 Dec 2020 14:14

IN BRIEF: Abingdon Health Raises GBP22 Million In AIM IPO

IN BRIEF: Abingdon Health Raises GBP22 Million In AIM IPO

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.